Imunon, Inc.·4

Jul 21, 4:15 PM ET

Faller Douglas Vincent 4

4 · Imunon, Inc. · Filed Jul 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Imunon (IMNN) CMO Douglas Faller Receives 3,082-Share Award

What Happened
Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (IMNN), received an award of 3,082 shares on July 17, 2026. The shares were reported at $1.83 each, valuing the grant at approximately $5,640. This was an acquisition via award (transaction code A) — stock granted in lieu of a portion of base salary.

Key Details

  • Transaction date: 2026-07-17
  • Filing date: 2026-07-21 (filed within the Form 4 two-business-day window)
  • Shares granted: 3,082
  • Price reported: $1.83 per share
  • Total value: ~$5,640
  • Footnote: stock granted in lieu of cash for portion of base salary (per filing)
  • Shares owned after the transaction: not specified in the provided filing

Context
This was a compensation-related stock award, not an open-market purchase or sale. Awards in lieu of cash are a routine form of executive compensation and do not, by themselves, indicate buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-07-17
Faller Douglas Vincent
Chief Medical Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-07-17$1.83/sh+3,082$5,64026,286 total
Footnotes (1)
  • [F1]Stock granted in lieu of cash for portion of base salary
Signature
/s/ Susan Eylward, Attorney-in-Fact for Douglas Faller|2026-07-21

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4